Document:

Exhibit 10.2a

                                AMENDED AGREEMENT

         AMENDED AGREEMENT dated this 4TH day of January 2005 , by and between
ConsultAmerica, Inc. (hereinafter "CA"), a Delaware Corporation, with offices
located at 13070 Addison Road, Roswell, Georgia 30075, Edward A. Sundberg,
President of CA and Gary B. Wolff, P.C., counsel to CA, with offices located at
805 Third Avenue, New York, New York.

         WHEREAS, CA has filed a Registration Statement with the United States
Securities and Exchange Commission (hereinafter the "SEC") on Form SB-2 which
Registration Statement indicates in Part II, Item 25, offering expenses totaling
seventy one thousand one hundred one dollars and fifty two cents ($71,101.52) of
which fifty thousand ($50,000) dollars are indicated as legal fees and expenses;
and

         WHEREAS, CA has agreed to pay all such costs as and when necessary and
required, or to otherwise accrue such costs on its books and records until it is
able to pay the full amount due, either from revenues or loans from its
President.

         NOW, THEREFORE, it is herewith agreed as follows: Absent sufficient
revenues to pay these amounts within three (3) months of the date of the CA
prospectus, CA's President agrees to loan CA the funds to cover the balance of
outstanding professional and related fees relating to CA's prospectus. If and
when loaned, the loan will be evidenced by a non-interest bearing unsecured
corporate note to be treated as a loan until repaid, if and when CA has the
financial resources to do so. Gary B. Wolff, P.C., CA's counsel, by signing this
Amended Agreement agrees in full to defer his legal fee in the manner set forth
in this Amended Agreement.

         The parties hereto understand that the above constitutes a binding
Agreement and that the contents thereof are referred to in the aforesaid
Registration Statement, both in Risk Factor number 2 and in the subheading
entitled "Liquidity" as found in the Management's Discussion and Analysis or
Plan of Operation section.

<PAGE>

         The above constitutes the entire Agreement between the parties hereto.

         IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the 3 day of November 2004.

CONSULTAMERICA, INC.

/s/
By: ________________________________
    Edward A. Sundberg, President

/s/
By: _________________________________
    Edward A. Sundberg, Individually

GARY B. WOLFF, P.C.

/s/
By:_________________________________
   Gary B. Wolff, PresidentEmployment Agreement between the Registrant and Joseph H. Crabb

 EXHIBIT 10.1 
  
 EMPLOYMENT AGREEMENT 
  
 THIS AGREEMENT is made as of the 1st day of January, 2005, between IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and Joseph H.
Crabb, of Falmouth, Maine (“Crabb”). 
  
 WITNESSETH: 
  
 In consideration of the mutual
promises hereinafter contained, the parties hereto agree as follows: 
  
 1. EMPLOYMENT AND TERM. Recognizing that Crabb desires to reduce his time commitment to his responsibilities on behalf of the Company, the Company hereby agrees to employ Crabb and Crabb hereby agrees to accept half-time employment by the
Company, subject to the provisions of this Agreement, for a term of one (1) year commencing on January 1, 2005, and ending on December 31, 2005. Except as provided in Section 6(e) below, this Agreement replaces and supersedes Crabb’s prior
Employment Agreement with the Company, which Agreement became effective April 29, 1999. 
  
 2. DUTIES OF CRABB. Crabb shall continue to be employed by the Company as its Vice President and Chief Scientific Officer, performing such duties consistent with such position as its Board of Directors shall assign to
Crabb from time to time. As an exempt employee, Crabb shall work those hours that are reasonably necessary to complete his assigned duties on behalf of the Company, with the understanding that it is expected that his time commitment to his position
responsibilities shall be half-time. Even though working a half-time schedule, Crabb shall serve the Company faithfully and diligently, using his best efforts to promote the interests of the Company. Crabb further agrees when called upon to serve as
a member of the Board of Directors of the Company. Any service as a director shall be part of Crabb’s expected time commitment to the Company and therefore performed without expectation of any additional compensation. 
  

	 	3.	COMPENSATION. 

  

	 	(a)	Base salary. As compensation for his half-time services hereunder, the Company shall pay Crabb a salary of $7,307.58 per month, the first payment being made in conjunction
with the Company’s January 15, 2005 payroll. 

  

	 	(b)	 Employee Benefits. Working a half-time schedule, Crabb shall be eligible for non-legally mandated benefits provided by the Company to its employees, such as
life insurance and disability insurance. Crabb shall be eligible to receive health insurance benefits under the same conditions as other employees of the Company subject to the terms and conditions of the Company’s health insurance plan. During
weeks in which a holiday falls, Crabb’s commitment to his position responsibilities shall be reduced by 4 hours (50% of the 8 hour holiday) to average 16 hours per week. Crabb shall earn 50% of the 20 vacation days earned by a full-time
employee with his 

 
number of years of service to the Company, which amounts to 80 hours per year. Crabb shall earn three sick days during the year (50% of the sick time earned
by full-time employees) and maintain his earned sick day bank in force for use in the event of a catastrophic illness or disability. Given the flexibility provided in Crabb’s work schedule, it is not anticipated that sick time will be needed in
a significant way to achieve the half-time work commitment. Crabb will still be eligible for a 401(k) Plan employer match in accordance with the terms of that Plan as it may be amended from time to time. 
  

	 	(c)	Existing Stock Options. This Agreement is not intended to modify the terms of any of Crabb’s outstanding stock option agreements with the Company.

  

	 	(d)	Cash Bonus. Neither this Agreement nor Crabb’s change of status to a half-time employee, shall disqualify Crabb from consideration for incentive compensation for the
2004 calendar year, payable on or about February 15, 2005. 

  

	 	4.	TERMINATION OF EMPLOYMENT. 

  

	 	(a)	Early Termination. Except as provided in subsections 4(b) and 4(c) below, this Agreement shall terminate at the end of its term as provided in Section 1 above.

  

	 	(b)	Termination by Company without Just Cause. The Company may terminate this Agreement and Crabb’s employment before the end of the one (1) year term by providing Crabb
written notice of such termination, provided however, Crabb shall still be entitled to receive as severance pay an amount equal to the salary that otherwise would have been paid during the remainder of the one (1) year term of this Agreement. Any
severance due shall be paid within thirty (30) days after the effective date of the early termination. 

  

	 	(c)	Termination for Just Cause. A majority of the Board of Directors of the Company may at any time terminate this Agreement and the employment of Crabb for just cause (as
hereinafter defined) upon seven (7) days’ written notice to Crabb. Upon the expiration of such seven (7) day period, Crabb’s employment with the Company shall cease, and from and after such date the Company shall have no further liability
or obligation to make any payments or provide any benefits which would otherwise be paid to Crabb hereunder, except as such have accrued on or before such date. 

  
 As used in this subsection (c), “just cause” shall be deemed to include only the following: 
  

	 	(i)	Crabb’s conviction of a felony involving moral turpitude or dishonesty; or 

  

	 	(ii)	Crabb’s persistent failure to comply with the reasonable directives or assignments of the Company’s Board of Directors, provided that such directives or assignments are
consistent with Crabb’s status and position as set forth in Section 2 of this Agreement; or 

	 	(iii)	Crabb’s persistent failure to devote his best efforts to the business and affairs of the Company in the manner contemplated by Section 2 of this Agreement; or

  

	 	(iv)	Crabb’s breach of the requirements of Section 5 of this Agreement or Attachment A as referenced therein. 

  

	 	(d)	Certain Events. In the event that (i) following the termination of Crabb’s employment pursuant to subsection (b) of this Section 4 the Company shall fail to pay Crabb
when due, or within ten (10) business days thereafter, all current sums payable to Crabb pursuant to said subsection (b), or (ii) following the termination of Crabb’s employment for any reason whatsoever, the Company or any successor or
assignee of the Company entitled to the benefits of this Agreement shall cease to conduct the business of the Company engaged in by the Company at the time of such termination, then, and in either such event, the covenants against competition set
forth in Section 5 of this Agreement shall be terminated and Crabb shall thereafter not be bound by the provisions thereof. The termination of said covenants against competition shall not alter or affect the obligation of the Company to make any
payments required to be made to Crabb pursuant to the provisions of subsection (b) of this Section 4. 

  

	 	5.	COVENANTS CONCERNING OUTSIDE ACTIVITIES. 

  

	 	(a)	Existing Covenants. Crabb hereby covenants that while employed by the Company, and after the termination of Crabb’s employment with the Company, whether before or after
the term of this Agreement and whether or not this Agreement is extended, he will abide by the terms of the “Agreement in Connection with Employment” dated September 19, 1988, between Crabb and the Company, a copy of which is appended
hereto as Attachment A. Notwithstanding the above, the parties agree that the prohibitions against competition set forth in Paragraph 4 of Attachment A shall not apply to Crabb as written, but instead that Crabb may, during or after
the term of his employment, work or consult for others in the human or animal health field except with respect to research and development relating to, or any business activity pertaining to, a “Protected Product or Technology” (as
hereafter defined) or any products or processes competitive with a Protected Product or Technology. 

  
 For the purposes of this Agreement, “Protected Product or Technology” shall mean and include: 
  

	 	(i)	First Defense® 

  

	 	(ii)	Wipe Out® Dairy Wipes, Mast Out® and other Nisin-containing products of the Company or its sublicensees 

	 	(iii)	Failure of Passive Transfer (FPT) products for calves 

  

	 	(iv)	DiffGAM 

  

	 	(v)	TravelGAM 

  

	 	(vi)	Crypto-Scan® 

  

	 	(vii)	The diagnosis of Johne’s Disease using Nisin or immunomagnetic separation 

  

“Protected Product or Technology” shall also mean and include any new products or technologies of the Company or any product improvements
with respect to (i) through (vii) above whether then existing or, to Crabb’s knowledge, under consideration or development by the Company. 
  
 This limitation on research, development and business activities shall remain effective throughout the term of Crabb’s association with the Company
as an employee, director and/or consultant, and for one (1) year after the date that Crabb no longer has any such association. Nothing contained in this subsection shall be construed to limit or waive Crabb’s confidentiality obligations to the
Company, whether under Attachment A or otherwise. 
  

	 	(b)	Covenant Concerning Employees. Crabb hereby covenants that while an employee, director and/or consultant with the Company, and for one (1) year after the date that Crabb no
longer has any such association, Crabb will not directly or indirectly hire any person then employed by the Company or persuade, induce or otherwise encourage any such person to leave the employ of the Company. 

  

	 	(c)	Survival of Obligations. Notwithstanding the termination of this Agreement, Crabb shall continue to be bound by the provisions of this Section 5 and such termination shall
not affect any obligations Crabb may have pursuant to this Section 5 or Attachment A as provided herein. 

  

	 	6.	MISCELLANEOUS. 

  

	 	(a)	Notice. Any notice given hereunder shall be set forth in writing and shall be hand-delivered or mailed, if to the Company, at the address of its principal offices on the date
upon which such notice is given, and if to Crabb, at the then current residential address of Crabb (as reflected on the records of the Company) by any of the aforesaid means. Any such notice shall be deemed effective on the earliest to occur of the
date actually delivered to the specified address; the second business day after being deposited in the United States mail, if sent by registered or certified mail, postage prepaid, return receipt requested; or the date actually received.

  

	 	(b)	 Death. In the event of the death of Crabb during the term of this Agreement while he shall be an employee of the Company, Crabb’s compensation pursuant
to Section 3 hereof shall cease as of the last day of the month in which Crabb’s death occurs. Any remaining amounts owing to Crabb pursuant to Section 3 hereof in respect to such month shall be paid to his estate or shall pass by applicable
laws of descent and 

 distribution. In the event of the death of Crabb after he has terminated his employment with the Company,
but prior to the payment of all amounts payable to him pursuant to the provisions of subsection (b) of Section 4 hereof, the remaining such amounts shall be paid to the representatives of Crabb’s estate. 
  

	 	(c)	Injunctive Relief. The parties agree that the extent of damage to the Company in the event of the breach by Crabb of the covenants contained in Section 5 of this Agreement
and/or Attachment A would be difficult or impossible to ascertain and that there would be no adequate remedy at law available to the Company in the event of such breach. Therefore, in the event of any such breach, the Company shall be
entitled to enforce any or all of such covenants by injunction or other equitable relief in addition to receiving damages or other relief to which the Company may be entitled. 

  

	 	(d)	Binding Effect; Assignment. This Agreement and the Company’s rights under this Agreement may be assigned or transferred by the Company to any successor in interest to
the Company or the business of the Company. This Agreement is a personal contract and the rights and interest of Crabb herein may not be sold, transferred, assigned, pledged or hypothecated by Crabb, and any such attempted sale, transfer,
assignment, pledge or hypothecation shall be null, void and of no effect. 

  

	 	(e)	Entire Agreement. Except as set forth in the next succeeding sentence, this Agreement contains the entire agreement between the parties hereto with respect to the
transactions contemplated herein and supersedes all prior agreements and understandings, written and oral, with respect to the subject matter hereof, and may not be amended or modified except by an instrument in writing signed by both parties
hereto. It is understood and agreed that the following additional agreements shall remain in full force and effect and shall not be superseded by this Agreement: (i) the “Agreement in Connection with Employment” dated September 19, 1988
and appended hereto as Attachment A (as amended by Section 5(a) of this Agreement), (ii) the provisions contained Section 3(c) of the Employment Agreement dated April 29, 1999 between Crabb and the Company, regarding nonqualified stock
options granted to Crabb, and (iii) all other incentive and nonqualified stock option agreements previously entered into between Crabb and the Company, which agreements remain in full force to the same extent they were in force before this Agreement
was executed. 

  

	 	(f)	Severability. If any provision of this Agreement is declared invalid, illegal or unenforceable, such provision shall be severed and all remaining provisions shall continue in
full force and effect. 

  

	 	(g)	Law Governing. This Agreement shall be governed by and enforced in accordance with the laws of the State of Maine 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement, intending the same to take effect as
a sealed instrument, as of the date first above written. 
  

							
	 	 	 	 	 IMMUCELL CORPORATION

				
	 By:
	 	 /s/ Joseph H. Crabb

	 	 By:
	 	 /s/ Michael F. Brigham

	 	 	 Joseph H. Crabb
	 	 	 	 Michael F. Brigham, President and CEO

				
	 	 	 	 	 By:
	 	 /s/ Anthony B. Cashen

	 	 	 	 	 	 	 Anthony B. Cashen, Chairman,

	 	 	 	 	 	 	 Compensation and Stock Option

	 	 	 	 	 	 	 Committee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]